Results 81 to 90 of about 519,396 (228)

Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System

Drug Discoveries & Therapeutics
Fosfomycin, with its unique mechanism of action, has emerged as a promising option for clinicians to combat antimicrobial resistance and the limited availability of effective drugs, which has led to an increase in associated adverse events (AEs). This study aims to explore the AEs caused by fosfomycin through data mining of the US FDA Adverse Event ...
Luxuan, Yang, Wenyong, Zhang, Xiujuan, Shen, Meiqin, Liu, Meiying, Wu, Dan, Xiao   +5 more
openaire   +2 more sources

Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. [PDF]

, 2013
Drug-drug interactions (DDI) account for 30% of all adverse drug reactions, which are the fourth leading cause of death in the US. Current methods for post marketing surveillance primarily use spontaneous reporting systems for learning DDI signals and ...
Bauer-Mehren, Anna, Harpaz, Rave, Iyer, Srinivasan V, Lependu, Paea, Shah, Nigam H   +4 more
core   +5 more sources

Argatroban-associated adverse events: an analysis based on FDA adverse event reporting system (FAERS)

Cardiovascular Toxicology
Abstract ObjectiveThis study aims to mine and analyze adverse events (AEs) of argatroban based on the FAERS database to better understand its safety and potential risks in the real world.MethodsData from the first quarter of 2004 to the third quarter of 2024 were collected, and researchers employed various signal mining methods such as ...
Changyu Ren, Guimu Guo, YiXuan Wang, Tingting Chen, Jintuo Zhou, Peiguang Niu, Jinhua Zhang   +6 more
openaire   +1 more source

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system

Frontiers in Pharmacology
BackgroundVortioxetine is a novel antidepressant belonging to the class of selective serotonin reuptake inhibitors. This study aims to comprehensively analyze the adverse events (AEs) associated with vortioxetine by analyzing the FDA Adverse Event Reporting System (FAERS) database.MethodsThis study collected reports of vortioxetine as primary suspected
Liangxia Li, Qianqian Xu, Liangfang Pang, Yarui Liu, Yuanyuan Lu   +4 more
openaire   +3 more sources

Recommended immunization schedules for persons aged 0 through 18 years -- United States, 2016 [PDF]

This schedule includes recommendations in effect as of January 1, 2016. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible.

core  

Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System

Therapeutic Advances in Drug Safety
Background: Clarithromycin is a widely used antibiotic, but its safety profile, particularly in different age groups, remains inadequately explored. Objectives: This study aims to characterize and illustrate the features of clarithromycin-related adverse
Haiyan Mai, Zhenpo Zhang, Yankun Liang, Jingping Zheng, Ling Su   +4 more
doaj   +1 more source

Vonoprazan-associated infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System

Therapeutic Advances in Drug Safety
Background: Prolonged or excessive use of acid suppressants may increase the risk of Clostridioides difficile infection (CDI) by altering the intestinal microecosystem.
Mengling Ouyang, Shupeng Zou, Qian Cheng, Xuan Shi, Yazheng Zhao, Minghui Sun   +5 more
doaj   +1 more source

Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System

Frontiers in Medicine
BackgroundCyclobenzaprine, a centrally-acting muscle relaxant, is widely used for the treatment of musculoskeletal pain. Despite its efficacy, concerns regarding its safety profile, particularly adverse events (AEs), have been increasingly reported. This
Jiakuan Tu, Jiakuan Tu, Chaoxiang Zhang, Chaoxiang Zhang, Shuihua Xie, Jianhua He, Hao Zhang   +6 more
doaj   +1 more source

Hearing disorder following COVID ‐19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System

, 2022
Congqin Chen, Fang Fu, Lingqing Ding, Jie Xiao   +3 more
openalex   +2 more sources

Committed to Safety: Ten Case Studies on Reducing Harm to Patients [PDF]

, 2006
Presents case studies of healthcare organizations, clinical teams, and learning collaborations to illustrate successful innovations for improving patient safety nationwide.
David Blumenthal, Douglas McCarthy
core